Group 1 - The new stock market was active in June, with a total of 6 new stocks listed, and 33 stocks recorded positive growth in the last 6 months, accounting for 71.74% [11][12][14] - In the Sci-Tech Innovation Board, the newly listed stock "Ying Shi Innovation" saw a monthly decline of over -4%, while "Hai Bo Si Chuang" and "Sheng Ke Nano" recorded monthly increases of over 20% [14][17] - In the Growth Enterprise Market, "You You Green Energy" and "Xin Heng Hui" were newly listed, with "Hong Gong Technology" and "Xin Heng Hui" achieving monthly growth rates of over 50% and 40% respectively [24][26] Group 2 - The main board saw the listing of "Zhong Ce Rubber," "Hai Yang Technology," and "Hua Zhi Jie," with "Jiang Nan New Material" achieving a monthly growth of over 19%, while "Hai Yang Technology" recorded a decline of over -43% [29][32] - The first-day price-to-earnings ratio (PE) for the Sci-Tech Innovation Board in June was 51.55 times, up from 20.04 times in May, indicating an increase in valuation [17][26] - The first-day opening valuation for the main board in June was 28.90 times, down from 39.90 times in May, reflecting a decrease in valuation despite an increase in first-day growth [34][35] Group 3 - The near-term key new stocks include "Yi Tang Co.," which focuses on dry stripping equipment and rapid thermal processing equipment, and has received approval from the regulatory authority [42][44] - The market size for dry stripping equipment is projected to grow, with the global market expected to reach $950 million in 2022, indicating a strong demand in the semiconductor manufacturing sector [44][45] - The competitive landscape for dry stripping equipment is characterized by a few major players, with "Yi Tang Semiconductor" holding a market share of 34.60%, positioning it as a leading player in the industry [45][46]

Core Viewpoint - The article highlights the growth and innovative business model of Shengke Nano, a leading third-party semiconductor testing laboratory in Suzhou, which has adopted a "Labless" approach to meet the increasing demand for specialized testing services in the semiconductor industry [1][3]. Company Overview - Shengke Nano was established in 2004 in Singapore and became Southeast Asia's largest third-party chip testing laboratory by 2011. The company was founded in Suzhou in 2012 by Li Xiaomin, who identified a growing need for specialized testing as the domestic semiconductor industry advanced [4]. - The company has developed a unique "Labless" business model, similar to the "Fabless" model in semiconductor manufacturing, allowing semiconductor firms to outsource testing and analysis to specialized third-party laboratories [1][3]. Financial Performance - Shengke Nano's revenue has shown significant growth, with figures of approximately 168 million yuan in 2021, 287 million yuan in 2022, and 394 million yuan in 2023. Corresponding net profits were 27.5 million yuan, 65.6 million yuan, and 98.5 million yuan, respectively [2]. - The company currently possesses analysis instruments valued at around 800 million yuan and is actively expanding its production capacity through strategic partnerships with top global analysis instrument suppliers [2]. Market Trends - The "Labless" model is gaining traction in the semiconductor industry, driven by the increasing complexity of semiconductor technology and the rising costs associated with in-house laboratory setups [1][3]. - Shengke Nano aims to replicate the success of TSMC, which took nearly 40 years to become a leader in the chip foundry industry, by leveraging its "Labless" model to enhance the efficiency and performance of semiconductor research and development [3]. Future Outlook - Shengke Nano projects that its revenue for the first quarter of 2025 will reach between 110 million to 120 million yuan, representing a year-on-year growth of 26.78% to 38.31% [2]. - The company is positioned to play a crucial role in the ongoing advancement of the semiconductor industry, particularly as the demand for specialized testing services continues to rise [4].

Group 1 - The new stock market activity has decreased, with the first-day price increase of new stocks on the Sci-Tech Innovation Board declining, while the opening board valuation has increased [1][13][17] - In March, the Sci-Tech Innovation Board's Shengke Nano was listed, achieving a first-day price increase of 241.41% and an opening board valuation of 154.01 times [1][17] - The ChiNext Board saw the listing of Zhejiang Huaye, Zhejiang Huayuan, and Xidian shares, with some stocks experiencing significant declines [1][25] Group 2 - The new stock issuance PE ratio for the Sci-Tech Innovation Board increased to 42.64 times in March, compared to 23.30 times in January [19][36] - The ChiNext Board's new stock issuance PE ratio rose to 17.56 times in March, up from 17.14 times in February [26] - The main board's new stock issuance PE ratio increased to 18.17 times in March, compared to 18.88 times in February [36] Group 3 - The report highlights key newly listed stocks since January 2023, including Shengke Nano and Hongjing Optoelectronics, which are recommended for attention [49] - The report lists 19 companies that have received approval from the China Securities Regulatory Commission, including Weigao Blood Purification and Yitang Technology, which are considered promising [45][46] - The report provides a detailed overview of the market position and competitive landscape of Shengke Nano, emphasizing its leading status in the semiconductor testing and analysis industry [56][57]

Core Viewpoint - Jiangsu's capital market has entered a new era with over 700 listed companies, showcasing significant growth and a strong focus on high-quality development, particularly in "hard technology" sectors [2][5][14]. Group 1: Growth of Listed Companies - Jiangsu has officially surpassed 700 listed companies, with 113 on the Sci-Tech Innovation Board and 48 on the Beijing Stock Exchange, maintaining a leading position nationally [2][5]. - The number of listed companies in Jiangsu has accelerated, with 320 new listings since the pilot registration system was implemented, accounting for over 45% of the total [5][6]. - The distribution of listed companies is concentrated in cities like Suzhou, Nanjing, and Wuxi, with Suzhou leading at 220 companies, particularly in electronics, biomedicine, and high-end equipment manufacturing [5][6]. Group 2: Investment in R&D - Over 80% of newly listed companies in Jiangsu are allocating funds for R&D and technological upgrades, with an average annual R&D investment exceeding 200 million yuan per company on the Sci-Tech Innovation Board [3][14]. - The total R&D investment from Jiangsu's "Sci-Tech Army" exceeded 20 billion yuan in 2023, with notable contributions from companies like Trina Solar and Huazhong Microelectronics [14][15]. Group 3: Industry Focus and Innovation - Jiangsu's listed companies are primarily engaged in cutting-edge industries such as biomedicine, integrated circuits, new energy, and intelligent manufacturing [14][15]. - The establishment of innovation centers, such as the one led by XCMG Machinery, aims to enhance collaboration across the supply chain and drive technological advancements [10]. Group 4: International Expansion - Jiangsu's listed companies are increasingly pursuing international markets, with companies like Hengrui Medicine accelerating their global presence through new drug approvals and overseas listings [11][23]. - In 2024, 15 companies from Jiangsu successfully listed overseas, raising a total of 4.418 billion yuan, indicating a strong trend towards internationalization [23]. Group 5: Regulatory Support and Market Stability - The Jiangsu Securities Regulatory Bureau is actively promoting policies to enhance market stability and support listed companies in navigating challenges, including cash dividend policies and mergers and acquisitions [20][21][22]. - In 2024, Jiangsu's listed companies implemented cash dividends totaling 132 billion yuan, ranking second nationally, reflecting a commitment to shareholder returns [21].

Core Viewpoint - Jiangsu's capital market has reached a new milestone with over 700 listed companies, reflecting a robust foundation for high-quality development and significant contributions to regional technological innovation [1][3][20]. Group 1: Growth of Listed Companies - Jiangsu has officially entered the "700+" era with a total of 700 listed companies, including 216 on the Shanghai Stock Exchange, 113 on the Sci-Tech Innovation Board, and 48 on the Beijing Stock Exchange [1][3]. - Since the implementation of the registration system, Jiangsu has added 320 new listed companies, accounting for over 45% of the total, indicating accelerated growth in the number and scale of listed companies [3][4]. - The average annual R&D investment for each Sci-Tech Innovation Board company exceeds 200 million yuan, highlighting the emphasis on innovation and technology upgrades [1][10]. Group 2: Regional Distribution and Industry Focus - Suzhou, Nanjing, and Wuxi are the top three cities in Jiangsu with over 100 listed companies each, with Suzhou leading at 220 companies, particularly strong in electronics, biomedicine, and high-end equipment manufacturing [3][4]. - Jiangsu's manufacturing sector is significant, with 549 manufacturing companies listed, representing nearly 80% of the total listed companies in the region [4][10]. Group 3: Innovation and Technology - Jiangsu's listed companies are heavily focused on "hard technology," with over 80% of new listings planning to use raised funds for R&D or technology upgrades [1][10]. - The total R&D investment of Jiangsu's Sci-Tech Innovation Board companies in 2023 exceeded 20 billion yuan, with notable contributions from companies like Trina Solar and Huazhong Microelectronics [10][11]. Group 4: Future Industries and New Opportunities - Jiangsu is actively cultivating future industries such as biomanufacturing, commercial aerospace, quantum technology, and humanoid robotics, with core enterprises generating over 500 billion yuan in revenue [14][15]. - Companies like XCMG Machinery and Lead Intelligent are leading in their respective fields, with significant advancements in high-end machinery and new energy equipment [7][8]. Group 5: Capital Market Development and Policies - Jiangsu's regulatory body is enhancing collaboration with local governments to promote a stable and healthy capital market, focusing on innovation and supporting private enterprises [12][20]. - The implementation of new policies has led to an increase in cash dividends among listed companies, with 648 companies distributing a total of 132 billion yuan in dividends in 2024 [18][19].

重仓收获超级回报。 作者 I 杨继云 报道 I 投资界PEdaily 这是罕见的一幕。 连续两天，丰年资本收获两个A股IPO——今天（3月2 5日），被誉为"芯片全科医院"的 胜科纳米挂牌科创板，开盘大涨超2 00%；而前一天，中国大陆规模最大的探针台设备制 造商矽电股份登陆创业板，首日同样大涨。 进一步看，丰年资本的重仓色彩尤为抢眼：20 1 9年投资矽电股份，单笔投入近9 000万， 以7.9 0%的占比成为最主要的机构投资人；两年后又一举成为胜科纳米背后占比最大的机 构类股东，持股7 .10%——背后回报不言而喻。 连续敲钟是一缕缩影，丰年资本正在迎来密集的收获期。 更早前，达利凯普、达梦数据 先后成功登陆A股，彼时两个爆款IPO后，身边一些同行不断研究起丰年打法。 眼前一级市场正在经历深刻变迁，科技投资成为绝对叙事主题。1 5个月内，连续4个科技 IPO，粗略计算总回报超过50亿元，丰年资本持续"本垒打"背后也许能够给当下行业突围 带来一缕启示。 久违盛况 两天两个A股硬核IPO 具体来看，这两家公司都是各自赛道内的"隐形冠军"。 此后，胜科纳米以"中立的第三方实验室" 定位 在国内市场站稳脚跟，2 ...